Ascletis Pharma Inc.

04/14/2021 | Press release | Distributed by Public on 04/14/2021 05:30

VOLUNTARY ANNOUNCEMENT - GANNEX ANNOUNCES THE FIRST COHORT DOSED IN A U.S. CLINICAL STUDY WITH THR-BETA AGONIST ASC41